Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Rpb1 CTD anticorps (pTyr1)

Il existe 4+ publications pour ce produit. L’anticorps anti-Rpb1 CTD Monoclonal Rat est utilisé pour la détection de Rpb1 CTD dans des échantillons de Humain. Il a été validé pour WB, IF, ICC, ChIP et IP.
N° du produit ABIN2668519
752,31 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 2 à 4 jours ouvrables

Aperçu rapide pour Rpb1 CTD anticorps (pTyr1) (ABIN2668519)

Antigène

Rpb1 CTD (RNA Polymerase II CTD)

Reactivité

  • 25
  • 7
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 10
  • 9
  • 6
Rat

Clonalité

  • 16
  • 9
Monoclonal

Conjugué

  • 21
  • 4
Cet anticorp Rpb1 CTD est non-conjugé

Application

  • 25
  • 19
  • 15
  • 9
  • 9
  • 5
  • 4
  • 3
  • 1
Western Blotting (WB), Immunofluorescence (IF), Immunocytochemistry (ICC), Chromatin Immunoprecipitation (ChIP), Immunoprecipitation (IP)

Clone

3D12
  • Épitope

    • 9
    • 5
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    pTyr1

    Fonction

    RNA pol II CTD phospho Tyr1 antibody (mAb) (Clone 3D12)

    Purification

    Protein G Chromatography

    Immunogène

    This antibody was raised against a synthetic peptide containing the RNA Pol II heptad repeat consensus sequence phosphorylated at tyrosine 1.

    Isotype

    IgG1
  • Indications d'application

    WB*: 1 - 2 μg/mL *Note: Many chromatin-bound proteins are not soluble in a low salt nuclear extract and fractionate to the pellet. Therefore, we recommend a High Salt / Sonication Protocol when preparing nuclear extracts for Western blot. In addition, we recommend the addition of 0.05 % Tween 20 to all blocking solutions to reduce background. This antibody is also available as an AbFlex engineered recombinant antibody. For details on the corresponding AbFlex Recombinant Antibody, see Catalog No. 91219.

    Restrictions

    For Research Use only
  • Concentration

    1 μg/μL

    Buffer

    Purified IgG in PBS with 30 % glycerol and 0.035 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions,Keep all reagents on ice when not in storage

    Stock

    -20 °C

    Stockage commentaire

    Some products may be shipped at room temperature. This will not affect their stability or performance. Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions for storage at -20°C for up to 2 years. Keep all reagents on ice when not in storage.

    Date de péremption

    24 months
  • Harlen, Trotta, Smith, Mosaheb, Fuchs, Churchman: "Comprehensive RNA Polymerase II Interactomes Reveal Distinct and Varied Roles for Each Phospho-CTD Residue." dans: Cell reports, Vol. 15, Issue 10, pp. 2147-2158, (2016) (PubMed).

    Laitem, Zaborowska, Isa, Kufs, Dienstbier, Murphy: "CDK9 inhibitors define elongation checkpoints at both ends of RNA polymerase II-transcribed genes." dans: Nature structural & molecular biology, Vol. 22, Issue 5, pp. 396-403, (2015) (PubMed).

    Zaborowska, Baumli, Laitem, OReilly, Thomas, OHare, Murphy: "Herpes Simplex Virus 1 (HSV-1) ICP22 protein directly interacts with cyclin-dependent kinase (CDK)9 to inhibit RNA polymerase II transcription elongation." dans: PLoS ONE, Vol. 9, Issue 9, pp. e107654, (2014) (PubMed).

    Mayer, Heidemann, Lidschreiber, Schreieck, Sun, Hintermair, Kremmer, Eick, Cramer: "CTD tyrosine phosphorylation impairs termination factor recruitment to RNA polymerase II." dans: Science (New York, N.Y.), Vol. 336, Issue 6089, pp. 1723-5, (2012) (PubMed).

  • Antigène

    Rpb1 CTD (RNA Polymerase II CTD)

    Autre désignation

    RNA Pol II CTD

    Sujet

    RNA pol II (RNA polymerase II) is responsible for synthesizing messenger RNA in eukaryotes. RNA pol II contains a carboxy terminal domain composed of heptapeptide repeats that are essential for polymerase activity. These repeats contain serine and threonine residues that are phosphorylated in actively transcribing RNA polymerase. In addition, RNA pol II, in combination with several other polymerase subunits, form the DNA binding domain of the polymerase, a groove in which the DNA template is transcribed into RNA. During the transcription cycle, the CTD of the large subunit of RNA pol II is reversibly phosphorylated. RNA pol II containing unphosphorylated CTD is recruited to the promoter, whereas the hyperphosphorylated CTD form is involved in active transcription. Phosphorylation occurs at sites within the heptapeptide repeat, at serine 2, serine 5, serine 7 and tyrosine 1. RNA pol II Tyrosine 1 phosphorylation is found during elongation and appears to activate transcription by suppressing RNA pol II termination.

    Poids moléculaire

    210 kDa

    ID gène

    5430

    NCBI Accession

    NP_000928
Vous êtes ici:
Chat with us!